October 5, 2021

Milo Sensors and UTHSA obtain first validation data with new alcohol sensing technology

Milo Sensors, Inc. has partnered with The University of Texas Health San Antonio to perform clinical validation of new discreet alcohol monitoring technology.

Santa Barbara digital health tech startup, Milo Sensors, just received the first independent on-skin validation of its novel enzymatic alcohol sensing technology from clinical research partners at UTHSA.

Last year, Milo Sensors was awarded a $1 Million Small Business Innovation Research (SBIR) grant by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health (NIH), which the company used to accelerate development of their novel enzymatic sensing technology. As part of the award, the company has contracted world-leading research institute The University of Texas Health Science Center at San Antonio (UTHSA) to perform independent clinical validation of the novel sensing technology.

The Clinical Research Study recently made the leap from in-lab validation with ethanol solutions to on-skin validation on human subjects. Research Scientist Dr. Peter Lamberg at Milo Sensors said of the most recent test “This first independent on-skin alcohol signal event detected is the proof of principle we have been building towards for the past couple of years. It’s amazing to see our technology come to life.”

UTHSA has previously validated other sensor technologies including ankle bracelets. Professor Dougherty remarked of the recent results “discreet wearable sensors have a lot of promise, and we are excited to be at the cutting edge together with Milo Sensors to help develop and validate this new technology.” PI of the Sub-Award, Assistant Professor TJ Moon noted that “this successful alcohol signal detected event is surely the first of many to come!”

Disclaimer: Research reported in this publication was supported by the National Institute On Alcohol Abuse And Alcoholism of the National Institutes of Health under Award Number R43AA026125. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

ION™ is a tracker product and is not intended to provide a substitute for a breathalyzer, nor does it quantify blood alcohol content. Abstinence is part of a healthy lifestyle. ION™ encourages abstinence, and is not a medical device. If you suspect that you may have an Alcohol Use Disorder, please contact a physician.

Related Posts